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Abstract
Background: Although recent studies indicate that renal ischemic preconditioning (IPC) protects the kidney from
ischemia-reperfusion (I/R) injury, the precise protective mechanism remains unclear. In the current study, we
investigated whether early IPC could upregulate hypoxia inducible transcription factor-1a (HIF-1a) expression and
could reduce endoplasmic reticulum (ER) stress after renal I/R and whether pharmacological inhibition of nitric
oxide (NO) production would abolish these protective effects.
Methods: Kidneys of Wistar rats were subjected to 60 min of warm ischemia followed by 120 min of reperfusion
(I/R group), or to 2 preceding cycles of 5 min ischemia and 5 min reperfusion (IPC group), or to intravenously
injection of NG-nitro-L-arginine methylester (L-NAME, 5 mg/kg) 5 min before IPC (L-NAME+IPC group). The results
of these experimental groups were compared to those of a sham-operated group. Sodium reabsorption rate,
creatinine clearance, plasma lactate dehydrogenase (LDH) activity, tissues concentrations of malonedialdehyde
(MDA), HIF-1a and nitrite/nitrate were determined. In addition, Western blot analyses were performed to identify
the amounts of Akt, endothelial nitric oxide synthase (eNOS) and ER stress parameters.
Results: IPC decreased cytolysis, lipid peroxidation and improved renal function. Parallely, IPC enhanced Akt
phosphorylation, eNOS, nitrite/nitrate and HIF-1a levels as compared to I/R group. Moreover, our results showed
that IPC increased the relative amounts of glucose-regulated protein 78 (GRP78) and decreased those of RNA
activated protein kinase (PKR)-like ER kinase (PERK), activating transcription factor 4 (ATF4) and TNF-receptor-
associated factor 2 (TRAF2) as judged to I/R group. However, pre treatment with L-NAME abolished these beneficial
effects of IPC against renal I/R insults.
Conclusion: These findings suggest that early IPC protects kidney against renal I/R injury via reducing oxidative
and ER stresses. These effects are associated with phosphorylation of Akt, eNOS activation and NO production
contributing thus to HIF-1a stabilization. The beneficial impact of IPC was abolished when NO production is
inhibited before IPC application.
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Background
Ischemia-reperfusion (I/R) injury, commonly seen in the
field of renal surgery or transplantation, is the leading
cause of acute renal failure [1]. Ischemic preconditioning
(IPC), defined as brief intermittent episodes of ischemia
alternating with reperfusion, increases the tolerance of
the ischemic kidneys against sustained I/R injury [2-4].
The IPC protective effect has been linked to various
mechanisms such as decrease of inflammatory response
[5], reduction of cellular apoptosis [6] and preservation
of energetic pool [7]. Recent reports demonstrated that
endoplasmic reticulum (ER) stress could play a critical
role in acute kidney injury in humans and in animal
model of I/R injury [8]. The stressed ER initiates the
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unfolded protein response (UPR) in order to reestablish
the ER homeostasis [9,10]. However, when the ER stress
is excessive, cell death is activated [1,11,12]. Recent stu-
dies demonstrated that IPC ameliorated I/R injury in
brain [13] and heart [14] through ER stress diminution.
However, its impact in ER stress in ischemic kidneys
remains unknown.
Several mediators have been described to contribute
to the protective effects of IPC, such as adenosine [15],
bradykinin [3], and reactive oxygen species [7]. In
addition, Chen et al. suggested that IPC increased the
pro-survival Akt signaling pathway [2] and enhanced
eNOS expression [16]. It has been reported that NO
plays an important role in both initiating and mediat-
ing IPC [2]. In agreement with this, reported studies
proved that exogenous addition of an NO donor can
reproduce the protective effect of IPC [15]. By con-
trast, a non-selective NO blocker aggravated renal
damage [2,17]. Additionally, the HIF-1a has emerged
as a key regulator of the molecular hypoxic response
[18,19]. Recent study reported that HIF-1a accumula-
tion by pharmacological preconditioning protects the
kidney against acute ischemic injury [20]. Semenza et
al. showed in their study that delayed IPC attenuates
both morphological and functional injuries and such
protective effect may be related to the increased
expression of HIF-1a [21].
In the current study, we firstly investigated the rela-
tionship between the early renal IPC and HIF-1a
expression after renal I/R and the possible involvement
of NO in this relation. Secondly, we showed the rele-




The study was performed with male Wistar rats weigh-
ing between 200-250 g. It respected the European
Union regulations (Directive 86/609/CEE) for animal
experiments. All animals (including those of sham
group) were anesthetized with an intraperitonial injec-
tion of ketamine (50 mg/kg) and were placed in a
supine position on a heating pad to maintain the body
temperature at 37°C. A midline laparatomy was per-
formed, and the vein and the artery of the left and the
right kidneys were isolated. In addition, catheters were
inserted (i) into the jugular vein, for administration of
mannitol (10%) and heparin (50 U/ml), (ii) into the car-
otid artery, for measurement of blood pressure (Press
Monitor BP-1, WPI, USA) and for blood samples collec-
tion and (iii) into the bladder, for collection of urine
samples. To induce renal ischemia, the renal pedicles
were occluded with non traumatic vascular clamps.
Reperfusion was initiated by removal of the clamps. At
the end of experiments, both kidneys were removed
under fully maintained anesthesia.
Experimental groups
Animals were randomly divided into 4 experimental
groups (n = 6 for each one, Figure 1): I/R group, renal
pedicles were clamped for 60 min and then reperfused
for 120 min. IPC group, just before the sustained ische-
mia, kidneys were subjected to 2 cycles of 5 min of
ischemia followed by 5 min of reperfusion. Soon after,
renal pedicles were clamped for 60 min then reperfused.
L-NAME+IPC group, 5 min before IPC application, a
non selective NOS inhibitor NG-nitro-L-arginine methy-
lester (L-NAME, 5 mg/Kg) was intravenously adminis-
tered to animals which were treated similar to IPC
group. The results of all these groups were compared to
those of a Sham group in which animals underwent
only dissection of renal pedicles.
Renal function
Blood and urine samples were collected to determine
creatinine and sodium concentration. Creatinine con-
centrations in plasma and urine were measured accord-
ing to the Jaffe’s reaction (BioMerieux Kit, France).
Sodium concentrations in plasma and urine were evalu-
ated by a flame photometer (BT.634, Biotecnica instru-
ments, Italy). Renal glomerular function was assessed by
creatinine clearance.
The formula to calculate the creatinine clearance (μl/
min/g) was: (Creatu . V)/Creatp
Creatp: creatinine concentration in plasma (μmol/l).
Creatu: Creatinine concentration in urine (μmol/l).
Figure 1 Experimental protocol. A schematic drawing of the
experimental protocol used to determine the effect of ischemic
preconditioning (IPC, 2 cycles of 5 min of ischemia (I) and 5 min of
reperfusion (R)), and the effect of intravenously injection of NG-nitro-
L-arginine methylester (L-NAME, 5 mg/kg) 5 min before IPC (L-
NAME+IPC group). In sham group, rats underwent only dissection of
renal pedicles; in I/R group, rats were subjected to 60 min of
bilateral renal ischemia followed by 120 min of reperfusion (n = 6 in
each group).
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V: urine flow (μl/min/g).
Renal tubules function was evaluated by sodium reabsorp-
tion rate. The formula to calculate the sodium reabsorption
rate (%) was: 100-[100 . (Nau . Creatp)/Nap . Creatu]
Nau: Sodium concentration in urine (mmol/l).
Nap: Sodium concentration in plasma (mmol/l).
Créatp: Creatinine concentration in plasma (μmol/l).
Créatu: Creatinine concentration in urine (μmol/l).
Determination of lactate dehydrogenase activity
Lactate dehydrogenase (LDH) activity in plasma was
used to evaluate kidney injury. The LDH activity was
quantified using a standard kit (BioMerieux Kit, France).
Determination of lipid peroxidation
Lipid peroxidation, used as an indirect index of the oxi-
dative injury induced by the reactive oxygen species,
was determined by measuring the formation of MDA
with the thiobarbiturate reaction [22].
Determination of nitrite and nitrate
Nitric oxide (NO) production in kidney was determined
by tissue accumulation of nitrite and nitrate, as pre-
viously described [23].
HIF 1a determination
Tissue HIF-1a concentration was quantified by binding
of HIF-1a to its specific oligonucleotide containing the
hypoxia response element, using the Trans AM HIF-1a
kit (Active Motif, Carlsbad, CA, USA). Results are
expressed as μg HIF-1a/mg protein [24].
Western blot assay
The renal tissues were homogenized as previously
described [25]. Proteins were separated by sodium dodecyl
sulfate polyacrylamide gel electrophoresis and transferred
into polyvinyldene fluoride membranes. Membranes were
immunoblotted with antibodies directed against GRP78,
ATF4, TRAF2, total and phosphorylated-PERK (Santa
Cruz Biotechnology, Santa Cruz, CA, USA), total and
phosphorylated Akt (Cell Signaling Technology Inc., Bev-
erly, MA, USA), eNOS and b actin (Sigma Chemical, St.
Louis, MO). The band of proteins was detected by using a
chemiluminescent kit (Bio-Rad Laboratories, Hercules,
CA, USA).and band intensities were quantified by densito-
metric scanning and the Quantity One software program
(Bio-Rad Laboratories, Hercules, CA, USA).
Statistical analysis
Data are expressed as mean ± SE (n = 6 for each group),
and were compared statistically by variance analysis
followed by the Student-Newman-Keuls test (Graph Pad
Prism software).
P < 0.05 was considered significant.
Results
IPC reduced lipid peroxydation and cytolysis and
improved renal function
As depicted in Figure 2, IPC application improved cell
integrity and decreased lipid peroxydation as compared
to I/R group. We found 780 ± 37 vs 1224 ± 191 IU/L (p
< 0.05) and 0.20 ± 0.01 vs 0.48 ± 0.02 nmol/mg prot (p
< 0.05) for plasma LDH activity and tissue MDA con-
centration, respectively. Subsequently, IPC statistically
enhanced functional parameters of ischemic kidneys
when compared to I/R group (Figure 3). Indeed, we
noted 118 ± 9 vs 36 ± 3 μL/min/g for creatinine clear-
ance and 96.8 ± 1.9 vs 70.0 ± 8.6% for sodium reabsorp-
tion rate. The L-NAME administration abolished the
protective effects of IPC and no statistical differences
Figure 2 Evaluation of lactate dehydrogenase activity in
plasma (A) and malonedialdehyde concentration in tissue (B).
Sham group: rats underwent only dissection; I/R group: renal
pedicles underwent 60 min of warm ischemia (I) followed by 120
min of reperfusion (R). IPC group: renal pedicles underwent 2 cycles
of 5 min of ischemia and 5 min of reperfusion, just before sustained
ischemia. L-NAME+IPC group: 5 min before IPC, 5 mg/kg of NG-
nitro-L-arginine methylester (L-NAME) was intravenously
administered. Results are presented as mean ± SEM (n = 6 in each
group). *P < 0.05 vs. Sham group, #P < 0.05 vs. I/R group, +P < 0.05
vs. IPC group.
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were observed between I/R and L-NAME+IPC groups
regarding all these parameters (p > 0.05).
IPC increased pAkt, eNOS, nitrite/nitrate and HIF 1a levels
The I/R injury resulted in a significant (p < 0.05) rise in
p-Akt level compared to sham group (Figure 4). This
level was further enhanced after IPC treatment (p < 0.05
vs I/R group). Additionally, IPC increased eNOS activa-
tion when compared to I/R group (p < 0.05). This in
turn resulted in a significant (p < 0.05) increase in tissue
nitrite/nitrate level. We found 13 ± 2 pmol/mg prot and
5.5 ± 1.5 pmol/mg prot respectively for IPC and I/R
group. Moreover, our results showed that IPC applica-
tion promoted the stabilization of HIF1a as referred to
I/R. We observed 293 ± 13 μg/mg protein for IPC
group and 160 ± 16 μg/mg prot for I/R group (p <
0.05).
The use of L-NAME before IPC did not affect the
results of p-Akt compared to IPC group. However, it
has declined significantly the level of eNOS (138 ± 4, p
< 0.05 vs IPC group), the concentration of nitrite/nitrate
(4.5 ± 0.9 pmol/mg prot, p < 0.05 vs IPC group) and
the level of HIF-1a (158 ± 35 μg/mg prot, p < 0.01 vs
IPC group) as referred to IPC group. It should be noted
that no statistical difference (p > 0.05) between L-
NAME+IPC and I/R groups was found for the amounts
of eNOS, nitrite/nitrate and HIF-1a (Figure 4).
IPC reduced ER stress
As indicated in Figure 5, our results showed an increase
in GRP78 (p < 0.05), in p-PERK, in ATF4 (p < 0.05) and
in TRAF2 (p < 0.05) after renal I/R compared to sham
group respectively. Interestingly, IPC improved ER
homeostasis. This was concomitant with a significant (p
< 0.05) increase of GRP78 level and a reduction of the
relative amounts of PERK, ATF4 and TRAF2 as judged
to I/R group (p < 0.05 respectively). However, the treat-
ment with L-NAME abolished the impact of IPC on ER
stress parameters.
Discussion
The detrimental effects of renal I/R injury are now well
recognized. Interestingly, IPC has been shown to protect
multiple organs [13,14,26] including kidney [15] from I/
R injury in animals. In humans, some investigations
have demonstrated the usefulness of IPC in cardiac [27],
and liver surgery and transplantation [28,29], but no
studies on human kidneys have been carried out [30].
The molecular bases of IPC involve the liberation of
several mediators that afterwards take place on a multi-
ple and complex intracellular signal pathways [31,32].
There is a biphasic temporal relationship between IPC-
induced protection and the duration of reflow [33]. It
offers an initial protection during 2-3 hours after reper-
fusion and a remote protection at the 12-24 hours that
lasts for 2 to 3 days. In fact, this acute window was
defined as the strongest form of in vivo protection
against myocardial I/R [30,34]. This early window acti-
vates various signal transduction pathways and second
messengers which then, serve as signals responsible for
activation of the molecular and genetic responses of the
delayed IPC [35]. In the current study, we were inter-
ested to explore the protective effect of IPC during early
reperfusion.
Among the numerous signaling pathways involved in
the protective mechanism of IPC, Akt signaling pathway
plays a crucial role in defending various organs against
I/R injury. Joo et al showed that acute renal IPC is asso-
ciated with rapid phosphorylation of the Akt and that
the inhibition of Akt pathway blocked the protective
effects of renal IPC [33]. In agreement with this, our
results revealed a marked increase of the phosphorylated
form of Akt after IPC in comparison to I/R group.
Strong evidences showed that eNOS is an important tar-
get of p-Akt [36,37]. Taken together, our results showed
Figure 3 Evaluation of creatinine clearance (A) and sodium
reabsorption rate (B). Sham group: rats underwent only dissection;
I/R group: renal pedicles underwent 60 min of warm ischemia (I)
followed by 120 min of reperfusion (R). IPC group: renal pedicles
underwent 2 cyles of 5 min of ischemia and 5 min of reperfusion,
just before sustained ischemia. L-NAME+IPC group: 5 min before
IPC, 5 mg/kg of NG-nitro-L-arginine methylester (L-NAME) was
intravenously administered. Results are presented as mean ± SEM (n
= 6 in each group). *P < 0.05 vs. Sham group, #P < 0.05 vs. I/R
group, +P < 0.05 vs. IPC group.
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that IPC increased Akt phosphorylation, which in turn
activated eNOS and NO generation to alleviate the I/R
injury of ischemic kidneys.
It has emerged that NO plays a key role in triggering
IPC phenomenon in different organs via its antioxidant
[2], anti-apoptotic [34] and anti inflammatory properties
[15]. It is known that inducible NOS (iNOS) activity
was not detected before and immediately after ischemia,
but it gradually increased after reperfusion [6]. In kid-
ney, a previous investigation has showed that the
expression and the activity of iNOS increase 24 h after
IPC application [33]. Besides, it has been observed that
pharmacological inhibition of NO synthesis or genetic
deletion of the iNOS gene augments mouse kidney sus-
ceptibility and mitigates the protection afforded by IPC
[15]. From these studies, the increase of iNOS expres-
sion could be considered as an important component of
long-term protection induced by the IPC in the kidney.
Nevertheless, eNOS-mediated NO production plays a
crucial role in the acute preconditioned kidney [6].
Interestingly, our study showed that IPC resulted in the
increase of nitrite/nitrate level which was markedly
higher than this of I/R group. However, pharmacological
inhibition of NOS with L-NAME abolished these benefi-
cial effects of IPC against renal I/R injury. These results
may reflect the critical role of NO and eNOS, at least
partially, to trigger mechanisms responsible for inducing
the protective effect of the early IPC.
Several regulatory molecules have been described to
activate various signaling pathways able to reduce renal
I/R injury. For instance, pharmacological up-regulation
of HIF-1a represents a novel strategy in the prevention
of acute kidney injury [19]. HIF-1a, a master regulator
of gene transcription, mediates many processes of adap-
tation to low oxygen tension during hypoxia and ische-
mia [24]. Nevertheless under normoxic conditions,
degradation of HIF-1a is mediated by oxygen-dependent
hydroxylation of specific prolyl residues of the regulative
alpha-subunits by HIF prolyl hydroxylases (PHD). It was
demonstrated that inhibition of HIF-1a degradation by
pharmacologic inhibition of PHD would confer protec-
tion against subsequent ischemic injury [18]. Recently, it
was proved that renal hypoxic conditioning increased
the expression of HIF-1a which correlated with the
decrease of oxidative stress [1,38]. In line with this, our
results clearly indicate that IPC application increased
the level of HIF-1a as compared to I/R. We found that
the IPC enhanced the stabilization of HIF-1a to protect
ischemic kidneys against reperfusion injury. However, L-
NAME treatment abolished this effect. Such results may
Figure 4 p-Akt, endothelial nitric oxide synthase, nitrite/nitrate and HIF1-a. A: Representative western blotting of p-Akt (upper panels) and
densitometric analysis (lower panels); B: Representative western blotting of endothelial nitric oxide synthase (eNOS) (upper panels) and
densitometric analysis (lower panels); C: Nitrite/nitrate levels; D: Hypoxia-induced factor-1a (HIF-1a) protein levels. Sham group: rats underwent
only dissection; I/R group: renal pedicles underwent 60 min of warm ischemia (I) followed by 120 min of reperfusion (R). IPC group: renal
pedicles underwent 2 cyles of 5 min of I and 5 min of R, just before sustained I. L-NAME+IPC group: 5 min before IPC, 5 mg/kg of NG-nitro-L-
arginine methylester (L-NAME) was intravenously administered. Results are presented as mean ± SEM (n = 6 in each group). *P < 0.05 vs. Sham
group, #P < 0.05 vs. I/R group, +P < 0.05 vs. IPC group.
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reflect the involvement of NO in the preservation of
HIF-1a stability in ischemic kidney. Zaouali et al.
demonstrated that NO could favor the stabilization of
HIF-1a in the liver [24]. Based on these findings and
our results, it thus seems that IPC ameliorates kidney
tolerance against I/R injury throughout enhancement of
NO induced HIF-1a stabilization.
The involvement of ER stress in renal cells has been
shown to be critical in acute kidney injury in humans
and in various animal models of I/R injury [39,40]. Sev-
eral factors including oxidative stress, disturbance of cal-
cium homeostasis, and over expression of normal and/or
incorrectly folded proteins, interfered with ER function
and induced ER stress [41]. The stressed ER triggered
the UPR which induces signal transduction events to
increase ER resident chaperones, to inhibit protein
translation, and to accelerate the degradation of
unfolded proteins [10]. Our results showed a marked
decline in the levels of p-PERK, ATF4, and TRAF2 and
an increase of GRP78 level in IPC group. Studies per-
formed during the last decade identified GRP78 as a
ubiquitous luminal resident protein of the ER that plays
a key role in assisting the corrected folding and secre-
tion of protein [42]. This protein can protect cells from
ER stress and its induction is crucial for maintaining the
viability of cells subjected to stress [43,44]. Hayashi et
al. found that induction of GRP78 by IPC reduced ER
stress and prevented delayed neuronal cell death [41].
Moreover, Hung et al. observed that blocking the induc-
tion of GRP78 sensitized the renal epithelial cells to oxi-
dative stress. Therefore, we could suggest that IPC
protected kidneys against renal I/R insults throughout
modulation of ER stress and that up regulation of
GRP78 made kidneys more resistant to the stressful
conditions. Nevertheless, this beneficial effect was abol-
ished when L-NAME had been administered before IPC
treatment. In line with this, Bachar et al. proved in pan-
creatic beta cells subjected to glucolipotoxic conditions,
that chronic inhibition of NO production exacerbates
ER stress [45]. Taken together, our results revealed that
IPC modulated ER stress through the activation of the
eNOS pathway, since NOS inhibitor counteracted the
protective effect of IPC to reduce ER stress. In addition,
Xu et al. strongly suggest in their study that the NO
increased the GRP78 expression. They proposed that
NO regulates the flux of Ca2+ between the mitochon-
dria, the Golgi and the ER. This results in activation of
the ER-stress response transcription factor ATF6 which
then translocates to the nucleus and activates ER stress-
responsive genes, such as GRP78 [46].
Figure 5 Western blot of GRP78 (A), total and phosphorylated-PERK (B), ATF4 (C) and TRAF2 (D) protein levels. The upper panels show
one representative blot of six independent experiments and the lower panels show densitometric analysis. Sham group: rats underwent only
dissection; I/R group: renal pedicles underwent 60 min of warm ischemia (I) followed by 120 min of reperfusion (R). IPC group: renal pedicles
underwent 2 cyles of 5 min of I and 5 min of R, just before sustained I. L-NAME+IPC group: 5 min before IPC, 5 mg/kg of NG-nitro-L-arginine
methylester (L-NAME) was intravenously administered. Results are presented as mean ± SEM (n = 6 in each group). *P < 0.05 vs. Sham group, #P
< 0.05 vs. I/R group, +P < 0.05 vs. IPC group.
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Conclusions
In conclusion, we found that IPC early protects kidney
against renal I/R injury via reducing oxidative and ER
stresses. These effects are associated with phosphoryla-
tion of Akt and activation of eNOS and also with stabili-
zation of HIF-1a. The beneficial impact of IPC is
abolished when NO production is inhibited before IPC
application.
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